Cassava Sciences, Inc. Warrant
Cassava Sciences, Inc. Warrant
Your view on SAVAW
Overview
What the company does, where it operates, and who runs it.
About Cassava Sciences, Inc. Warrant
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Richard Jon Barry
- Headquarters
- 6801 N. Capital of Texas Hwy, Bldg 1, Austin, TX, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Richard Jon Barry
- Headquarters
- 6801 N. Capital of Texas Hwy, Bldg 1, Austin, TX, US
Cassava Sciences, Inc. is a biotechnology firm currently in the clinical development stage, dedicated to discovering therapies for neurodegenerative disorders. Their key therapeutic asset is simufilam, a small molecule drug that has already completed its Phase 2b clinical evaluation. Furthermore, the company is advancing SavaDx, a diagnostic tool utilizing blood-based biomarkers for the early detection of Alzheimer's disease. Incorporated in 1998, the organization was previously known as Pain Therapeutics, Inc. until its name change to Cassava Sciences, Inc. in March 2019. The company's headquarters are located in Austin, Texas.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Cassava Sciences, Inc. Warrant, and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Cassava Sciences, Inc. Warrant. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Cassava Sciences, Inc. Warrant. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Cassava Sciences, Inc. Warrant. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Cassava Sciences, Inc. Warrant. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Cassava Sciences, Inc. Warrant valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Cassava Sciences, Inc. Warrant, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Cassava Sciences, Inc. Warrant executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Cassava Sciences, Inc. Warrant. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Cassava Sciences, Inc. Warrant. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Cassava Sciences, Inc. Warrant. Press releases and market coverage, newest first.